The Lupus Research Alliance Lupus Industry Council (LIC) met a key objective with the recent publication in the medical journal Arthritis & Rheumatology reporting on a new tool to better measure the effectiveness of potential drug treatments in clinical trials. The LIC aims to bring industry and academia together to work collaboratively, along with the […] READ MORE
March 29, 2018 Selena Gomez’s first design collaboration with PUMA, is the highly anticipated Phenom Lux—a shoe that is made to stand out and help out. Designed for training, but styled for slaying, Phenom Lux allows women not only to perform, but also take action. For this important first design collaboration between Selena and PUMA, […] READ MORE
Source: Vogue, March 28, 2018 Selena Gomez is dipping a toe into sneaker design. Today, the singer revealed her first collaboration as brand ambassador for Puma. The sleek, all-white style, known as the Phenom Lux, comes with gold accents and a removable ankle bracelet, and is best worn with a pair of Puma’s new sheer […] READ MORE
Source: Ablynx Press Release 3.26.18 Ablynx today announced that the Phase II dose-ranging study of vobarilizumab, the Company’s anti-IL-6R Nanobody®, did not meet the primary endpoint of dose response based on the modified BILAG-based combined lupus assessment (mBICLA) at Week 24. The primary endpoint of the study was the percentage of subjects who achieved a response […] READ MORE
March 23, 2018 The Omnibus Appropriations bill for Fiscal Year 2018 that passed today includes key provisions the Lupus Research Alliance and lupus advocates have worked for all year. Lupus advocates, participating just days before for our annual March Capitol Hill Day, had requested program funding for 2019 and had asked legislators to also finish […] READ MORE
March 21, 2018 Lupus Research Alliance-Funded Scientists Find Potential Target to Treat Kidney Disease Novel research initially funded by the Lupus Research Alliance through a grant to Hospital for Special Surgery scientists significantly advanced understanding of kidney damage in lupus. As reported by Hospital for Special Surgery: A protein that helps regulate the body’s […] READ MORE
Advocate for Lupus – Contact Your Legislators! March 21, 2018 The color purple and the word lupus filled the halls of the U.S. Capitol yesterday as over 90 determined advocates visited nearly 100 representatives, senators and staff to share why we need their support for lupus research. And we thank the […] READ MORE
Join Us on the Hill March 20 as a Virtual Advocate for Lupus! Congress will be seeing purple next week when advocates representing the Lupus Research Alliance visit them Tuesday March 20 to convey why we need more funds for lupus research. We are proud to continue our March Hill Day […] READ MORE
Bacteria Could be to Blame for Autoimmune Attacks March 12, 2018 Innovative novel research, co-funded by the Lupus Research Alliance, has produced a significant discovery about the role of bacteria and points to the potential for a vaccine or treatment that might prevent an autoimmune attack by suppressing specific bacteria. Led […] READ MORE
Lupus: Patient Voices Report Released Today We are pleased to announce the release of Lupus: Patient Voices, a comprehensive report based on input from the Externally-led Lupus Patient-Focused Drug Development (PFDD) Meeting and pre-meeting survey conducted last fall. This report includes data and personal accounts from people with lupus on symptoms, daily disease impacts, current […] READ MORE
Lupus Industry Council Study Finds Inconsistency of ANA Tests A new study funded by the Lupus Research Alliance Lupus Industry Council shows that not all individuals who have been diagnosed with lupus remain positive for antinuclear antibodies (ANA) despite the long-held scientific belief to the contrary. Importantly, this study also reveals that whether a person […] READ MORE
NIH program to accelerate therapies for arthritis, lupus releases first datasets Collaborative effort provides important clues about potential research targets NEW YORK, NY. Feb. 21, 2018. Datasets characterizing individual cells in rheumatoid arthritis and systemic lupus erythematosus disease tissue from the Accelerating Medicines Partnership for Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Phase I […] READ MORE
